C5orf66-AS2

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, C5orf66-AS2 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated C5orf66-AS2 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher C5orf66-AS2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated C5orf66-AS2 expression acts as an unfavorable survival marker, although some lineages such as HNSC and UCS show a favorable association.

ACC, HNSC, and KICH are the cancer types where C5orf66-AS2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
ACCDFSTertileII,III,IV0.2870.591.00934view →
HNSCOSTertileAll0.8310.716.00434view →
KICHOSTertileIII,IV0.1780.847<.00127view →
SKCMOSTertileAll0.7260.879.00527view →
UCSDFSTertileII,III,IV0.6990.339.01824view →
KIRPDFSTertileAll0.6980.882.00115view →
BLCAOSTertileIII,IV0.8130.518.02012view →
READDFSTertileIV0.0950.697.0149view →
THYMDFSTertileII,III,IV0.2620.769.0326view →
LUADOSTertileAll0.1690.426.0426view →
BRCADFSTertileAll0.9230.891.0254view →
LIHCOSTertileAll0.6610.796.0303view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

C5orf66-AS2–ACC (DFS)

Kaplan–Meier survival curve for C5orf66-AS2 RNA-high vs -low samples in ACC.

Open the ACC breakdown →

Exploration